Magnetic field experimentation is noted in the literature. If my memory
serves me correct, your mentor, Dr Iacono participated in one that was
published. I believe that this was before he 'rediscovered' pallidotomy
which has practically beaten Parkinson's Disease as a disease, paraphrasing
his words.
The abstracts in my archive concerning such studies are these:
Unique Identifier
95080903
Authors
Sandyk R.
Institution
Neuro Communication Research Laboratories, Danbury, CT 06811.
Title
Improvement in word-fluency performance in Parkinson's disease by
administration of electromagnetic fields. [Review]
Source
International Journal of Neuroscience. 77(1-2):23-46, 1994 Jul.
Abstract
The association between degeneration of the nigrostriatal dopamine (DA)
system and the motor manifestations of Parkinson's disease (PD) provided
the impetus for the development of DA replacement therapy. However,
clinical experience has demonstrated that DA-ergic drugs, while
attenuating the motor symptoms of PD, have little or no consistent effect
on the mental and cognitive symptoms of the disease which are thought to
be related partly to degeneration of the meso-cortico-limbic DA system.
Thus, failure of DA-ergic drugs to improve the mental and cognitive
deficits of PD indicates that these agents cannot fully restore DA
functions in the meso-cortico-limbic circuits. The present communication
concerns five fully medicated Parkinsonian patients in whom application of
a series of treatments with electromagnetic fields (EMF) of extremely low
intensity (in the picotesla range) and frequency (5-8Hz) produced a
dramatic improvement in performance on Thurstone's World-Fluency Test, a
sensitive marker of frontal lobe functions. These findings suggest that in
contrast to DA replacement therapy application of low intensity EMF may
improve frontal lobe functions in patients with PD presumably by
augmenting DA activity in the mesocortical system. As deficiency of the
frontal DA system has been implicated also in the development of akinesia
and freezing in PD these observations may explain the beneficial effects
of EMF on the motor manifestations of the disease. [References: 150]
<2>
Unique Identifier
95080907
Authors
Sandyk R. Iacono RP.
Institution
NeuroCommunication Research Laboratories, Danbury, CT 06811.
Title
Reversal of micrographia in Parkinson's disease by application of
picoTesla range magnetic fields.
Source
International Journal of Neuroscience. 77(1-2):77-84, 1994 Jul.
Abstract
Micrographia, a common and often early sign of Parkinson's disease (PD),
is a sensitive clinical marker of the severity of bradykinesia and
rigidity in the disease. As micrographia may be reversed by treatment with
dopaminergic drugs and may emerge during therapy with neuroleptic agents,
it is thought to reflect striatal dopaminergic deficiency. It has been
reported recently that external application of picoTesla range magnetic
fields (MF) produced a dramatic improvement in the motor symptoms of PD
suggesting that these weak MF enhance striatal dopaminergic
neurotransmission. In the present communication, we present a 61 year old
patient with PD in whom picoTesla range MF attenuated the severity of
bradykinesia and rigidity, improved postural stability, and rapidly
reversed the micrographia within 30 minutes after termination of
treatment. In contrast, sham (placebo) MF did not influence the severity
of the motor symptoms of the disease or the associated micrographia. This
report demonstrates the antiParkinsonian effect of picoTesla range MF and
highlights the unique efficacy of these weak MF in the therapy of
Parkinsonism.
<3>
Unique Identifier
95013078
Authors
Awerbuch GI. Sandyk R.
Institution
Department of Neurology, Bay Medical Center, Bay City, Michigan 48706.
Title
Autonomic functions in the early stages of Parkinson's disease.
Source
International Journal of Neuroscience. 74(1-4):9-16, 1994 Jan-Feb.
Abstract
Disturbances of autonomic nervous functions are common in patients with
Parkinson's disease (PD) and may develop as a result of pathological
changes in centers of autonomic regulation such as the hypothalamus,
brainstem, and sympathetic ganglia. We examined cardiovascular reflexes
using bedside, noninvasive procedures in 20 unmedicated PD patients with
early stages of the disease (stage 1 and 2 on the Hoehn and Yahr's scale).
Sixteen patients (80%) exhibited some degree of autonomic nervous system
dysfunction. These included predominantly cardiovascular functions
mediated via the parasympathetic system. Our findings demonstrate: (a) a
high prevalence of autonomic disturbances in early stage PD, and (b) that
dysregulation of parasympathetic cardiovascular control mechanisms is a
major feature of dysautonomia in early, unmedicated PD patients.
<4>
Unique Identifier
95013064
Authors
Sandyk R.
Institution
NeuroCommunication Research Laboratories, Danbury, CT 06811.
Title
Treatment of Parkinson's disease with magnetic fields reduces the
requirement for antiparkinsonian medications.
Source
International Journal of Neuroscience. 74(1-4):191-201, 1994 Jan-Feb.
Abstract
Recently, I reported that extracranial treatment with picoTesla range
magnetic fields (MF) is an effective, safe, and revolutionary modality in
the management of Parkinsonism including those patients manifesting
levodopa-induced motor complications. This treatment, which has emerged as
a potentially more advantageous modality than pharmacologic therapy, also
produces improvements in nonmotor aspects of the disease including mood,
cognitive functions, sleep, pain, appetite, autonomic functions, and
sexual behavior, which are usually minimally, if at all, ameliorated by
long term therapy with levodopa or anticholinergic agents. The present
communication concerns a 69 year old Parkinsonian patient who, following a
series of two treatments with extracranial picoTesla range MF on two
separate days, improved to the point where he was able to discontinue most
of his antiparkinsonian medications for a period of two weeks without
experiencing deterioration in symptoms. On the third week he began to
develop recurrence of symptoms and resumed taking his regular medications.
At the end of the fourth week the patient received a series of four
magnetic treatments on four successive days after he completely
discontinued his antiparkinsonian medications. During this period he
experienced a remarkable improvement in motor disability as well as in
cognitive functions (i.e., visuospatial performance), mood, sleep,
appetite, bowel functions and resolution of pain in the lower extremity.
This report attests to the antiparkinsonian efficacy of picoTesla range MF
and suggests that this treatment, when applied on a regular basis, may
reduce the requirement for antiparkinsonian medications. This observation,
when confirmed in a larger cohort of patients, may carry important
implications for the therapy of Parkinsonism as it may offer an
alternative treatment for patients who develop levodopa failure or
experience intolerable side effects from dopaminergic medication. The
observation that magnetic treatment improved the patient's symptoms while
being off dopaminergic therapy supports the role of nondopaminergic
mechanisms in the pathophysiology of Parkinsonism.
<5>
Unique Identifier
94327299
Authors
Sandyk R.
Institution
NeuroCommunication Research Laboratories, Danbury, CT 06811.
Title
Reversal of a visuoconstructional deficit in Parkinson's disease by
application of external magnetic fields: a report of five cases.
Source
International Journal of Neuroscience. 75(3-4):213-28, 1994 Apr.
Abstract
Visuoperceptive and visuomotor deficits are among the most frequently
encountered abnormalities in neuropsychological testing of patients with
Parkinson's disease, being present in up to 90% of cases. Clinically, the
presence of visuoperceptive and visuomotor impairment may not be noted by
Parkinsonian patients but may contribute to various functional
disabilities including difficulties operating a vehicle, ambulating, and
dressing. The present communication concerns five medicated Parkinsonian
patients who responded to extracranial treatment with magnetic fields in
the picotesia range intensity with improvement in motor, behavioral, and
autonomic functions as well as visuoconstructional tasks as demonstrated
on the Bicycle Drawing test. Specifically, prior to treatment with
magnetic fields these patients failed to draw the spokes in the wheels of
a bicycle that extended completely to the periphery of the rim. I
considered this observation to reflect a specific visuoconstructional
deficit inherent to the Parkinsonian disease process. This
visuoconstructional impairment was reversed, however, by external
applications of magnetic fields. The report supports prior observations
demonstrating that picotesla range intensity magnetic fields may bring
about reversal of specific cognitive deficits in Parkinsonian patients.
John Cottingham "The parkinsn list brings Knowledge, Comfort, Hope, and
Friendship to the parkinsonian world."
Parkinson's Chat on the Undernet 8:30 PM CST -6 Daily.
If you access the Internet through a provider with a
[log in to unmask] PPP/SLIP account, free IRC chat software is available. WFD
